ARTMS® commercializes novel technologies and products for the production of medical isotopes using cyclotrons.
ARTMS has been acquired by Telix Pharmaceuticals
Telix today announces the completion of the acquisition of ARTMS Inc., a leader in “next generation” cyclotron isotope production.
We are delighted to welcome the @artms_inc team, and their highly differentiated technologies to the Telix Group.
More: https://t.co/lNgLNilszC
Telix today announces it has entered into an agreement to acquire radioisotope production technology firm ARTMS Inc., its cyclotron-based isotope production platform, manufacturing plant and stockpile of ultra-pure radio-metals for target production.
https://t.co/5ehL8SfXzC
As we embark on the new year, ARTMS is deeply grateful for the milestones attained in the past year, a testament to the hard work and dedication of our exceptional team, along with the unwavering support from our valued partners and customers. Here’s to continued success in 2024!
Wishing our incredible partners and customers a #HappyThanksgiving!
Your trust and collaboration have fueled our success, and we're grateful for the journey we've shared.
Here's to continued growth and prosperity – thankful for the privilege of working together.
Global isotope shortages? 🔬
This business in #Burnaby understands the assignment. 💡
@ARTMS_Inc's tech allows medical facilities to produce their own isotopes. 🥼
Discover how they're reshaping medical imaging with help from PacifiCan funding:
👉🏼 https://t.co/4e3AmL9Vj2
The future of #medicalisotope production has arrived with ARTMS.
Give patients the hope they deserve with #diagnostics on demand.
Learn more by visiting our website: https://t.co/ySYsVXuZ00
#NuclearMedicine
Another productive year for ARTMS at the 36th Annual Congress of the European Association of Nuclear Medicine (EANM) in Vienna.
A great opportunity to connect with current and future partners and collaborators.
#EANM23#NucMed#Cyclotron#Radiopharmaceuticals#MedicalIsotope
ARTMS excited and honoured to receive $5M investment funding from @PacifiCan via Business Scale-Up program, expanding #medicalisotope production to address global shortages and meet patient demand: https://t.co/lBegJkNr3s
Thank you, Ministers @HarjitSajjan & @terrybeech!
We’re #hiring. ARTMS is looking to hire a Vice President, Sales & Marketing.
Come join our fast-growing team as we continue making advances in #nuclearmedicine with state-of-the-art novel technologies.
Apply today: https://t.co/uQPyhvtCH8
#remotejobs#radiopharmaceuticals
Another successful @SNM_MI Annual Meeting!
It was great meeting with customers and suppliers. We look forward to reconnecting soon.
#nuclearmedicine#radioisotopes
We’re #hiring.
ARTMS is looking to hire a Quality Assurance Coordinator.
Come join our fast-growing team as we continue making advances in #nuclearmedicine with state-of-the-art novel technologies.
Apply today: https://t.co/MGuxjxajRG
#bcjobs#careers
We’re #hiring.
ARTMS is looking to hire a Product Development / Quality Engineer.
Come join our fast-growing team as we continue making advances in #nuclearmedicine with state-of-the-art novel technologies.
Apply today!
#bcjobs#careers https://t.co/SPacIKH8UN
ARTMS Chief Innovation Officer, Dr. Michael Cross, discusses with @innovate_bc the successful journey and exciting future of ARTMS in leading the enhancement of human health through #medicalisotope innovation empowering the #NuclearMedicine community.
Burnaby-based @ARTMS_Inc is combining world-class talent with leading-edge innovation. Their breakthrough technology is ensuring more people can access the treatments they need.
Read more about how ARTMS is changing the future of healthcare.
https://t.co/AhOZKdC0PK
In honour of International Day of Women and Girls in Science, 11 February, we highlight women at ARTMS who are pivotal in our mission to lead the enhancement of human health through #medicalisotope innovation empowering the #NuclearMedicine community.
#idwgis#womeninstem